Acer Therapeutics Inc. Business Finance Contracts & Agreements

102 Contracts & Agreements
Browse by Subcategory
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
First Amendment to Bridge Loan Agreement between Acer Therapeutics Inc. and Zevra Therapeutics, Inc.
Modification Agreements
Acer Therapeutics Inc.
Pharmaceuticals
2023
Amendment No. 1 to Unsecured Promissory Note between Acer Therapeutics Inc. and Christopher Schelling
Note Agreements
Acer Therapeutics Inc.
Pharmaceuticals
2023
Security Agreement between Acer Therapeutics Inc. and Zevra Therapeutics, Inc. dated August 30, 2023
Security Agreements
Acer Therapeutics Inc.
Pharmaceuticals
DE
2023
Bridge Loan Agreement between Acer Therapeutics Inc. and Zevra Therapeutics, Inc. dated August 30, 2023
Loan Agreements
Acer Therapeutics Inc.
Pharmaceuticals
NY
2023
Warrant to Purchase Common Stock Agreement between Acer Therapeutics Inc. and SWK Funding LLC (June 16, 2023)
Warrant Agreements
Acer Therapeutics Inc.
Pharmaceuticals
DE
2023
Unsecured Promissory Note between Acer Therapeutics Inc. and Christopher Schelling dated June 22, 2023
Note Agreements
Acer Therapeutics Inc.
Pharmaceuticals
2023
Securities Purchase Agreement between Acer Therapeutics Inc. and Purchasers (March 21, 2023)
Purchase Agreements
Acer Therapeutics Inc.
Pharmaceuticals
NY
2023
Common Stock Purchase Warrant Agreement between Acer Therapeutics Inc. and Holder (2023)
Warrant Agreements
Acer Therapeutics Inc.
Pharmaceuticals
2023
Pre-Funded Common Stock Purchase Warrant Agreement between Acer Therapeutics Inc. and Holder (2023)
Warrant Agreements
Acer Therapeutics Inc.
Pharmaceuticals
2023
Amendment Agreement to Secured Convertible Notes by Acer Therapeutics Inc., MAM Aardvark, LLC, and Marathon Healthcare Finance Fund, L.P.
Modification Agreements
Acer Therapeutics Inc.
Pharmaceuticals
NY
2023
Warrant to Purchase Common Stock between Acer Therapeutics Inc. and SWK Funding LLC (January 30, 2023)
Warrant Agreements
Acer Therapeutics Inc.
Pharmaceuticals
DE
2023
Second Amendment to Credit Agreement among Acer Therapeutics Inc., SWK Funding LLC, and Lenders
Credit Agreements
Acer Therapeutics Inc.
Pharmaceuticals
DE
2023
Extension Agreement to Credit Agreement among Acer Therapeutics Inc., MAM Aardvark, LLC, and Lenders (December 2022)
Modification Agreements
Acer Therapeutics Inc.
Pharmaceuticals
NY
2023
Securities Purchase Agreement between Acer Therapeutics Inc. and Investors (November 29, 2022)
Purchase Agreements
Acer Therapeutics Inc.
Pharmaceuticals
DE
2022
Warrant Agreement to Purchase Common Stock between Acer Therapeutics Inc. and SWK Funding LLC
Warrant Agreements
Acer Therapeutics Inc.
Pharmaceuticals
DE
2022
First Amendment to Credit Agreement among Acer Therapeutics Inc., SWK Funding LLC, and Lenders (August 19, 2022)
Credit Agreements
Acer Therapeutics Inc.
Pharmaceuticals
DE
2022
Synthetic Royalty Agreement among Acer Therapeutics Inc., MAM Aardvark, LLC, and Marathon Healthcare Finance Fund, L.P. dated March 4, 2022
Financing Agreements
Acer Therapeutics Inc.
Pharmaceuticals
DE
2022
Guarantee and Collateral Agreement among Acer Therapeutics Inc., Grantors, and MAM Aardvark, LLC as Agent
Guaranty Agreements
Acer Therapeutics Inc.
Pharmaceuticals
NY
2022
Credit Agreement among Acer Therapeutics Inc., MAM Aardvark, LLC, and Lenders dated March 4, 2022
Credit Agreements
Acer Therapeutics Inc.
Pharmaceuticals
NY
2022
Acer Therapeutics Inc. Secured Convertible Note Agreement with MAM Aardvark, LLC/Marathon Healthcare Finance Fund, L.P.
Note Agreements
Acer Therapeutics Inc.
Pharmaceuticals
NY
2022
Acer Therapeutics Inc. Secured Convertible Note Purchase and Security Agreement with MAM Aardvark, LLC and Purchasers (March 2022)
Note Agreements
Acer Therapeutics Inc.
Pharmaceuticals
DE
2022
Warrant to Purchase Common Stock Agreement between Acer Therapeutics Inc. and SWK Funding LLC (March 2022)
Warrant Agreements
Acer Therapeutics Inc.
Pharmaceuticals
DE
2022
Guarantee and Collateral Agreement between Acer Therapeutics Inc. and SWK Funding LLC, dated March 4, 2022
Guaranty Agreements
Acer Therapeutics Inc.
Pharmaceuticals
NY
2022
Credit Agreement among Acer Therapeutics Inc., SWK Funding LLC, and Lenders dated March 4, 2022
Credit Agreements
Acer Therapeutics Inc.
Pharmaceuticals
DE
2022
Waiver and Payment Amendment Agreement between Acer Therapeutics Inc. and Relief Therapeutics Holding AG
Waiver Agreements
Acer Therapeutics Inc.
Pharmaceuticals
NY
2021
Acer Therapeutics Inc. 2018 Stock Incentive Plan Stock Option Grant and Agreement
Warrant Agreements
Acer Therapeutics Inc.
Pharmaceuticals
TX
2021
Security Agreement between Acer Therapeutics Inc. and Relief Therapeutics Holding AG dated January 25, 2021
Security Agreements
Acer Therapeutics Inc.
Pharmaceuticals
NY
2021
Promissory Note between Acer Therapeutics Inc. and Relief Therapeutics Holding AG dated January 25, 2021
Note Agreements
Acer Therapeutics Inc.
Pharmaceuticals
NY
2021
Securities Purchase Agreement between Acer Therapeutics Inc. and Investors (July 24, 2020)
Purchase Agreements
Acer Therapeutics Inc.
Pharmaceuticals
DE
2020
Registration Rights Agreement between Acer Therapeutics Inc. and Lincoln Park Capital Fund, LLC (April 30, 2020)
Registration Rights Agreements
Acer Therapeutics Inc.
Pharmaceuticals
NY
2020
Purchase Agreement between Acer Therapeutics Inc. and Lincoln Park Capital Fund, LLC (April 30, 2020)
Purchase Agreements
Acer Therapeutics Inc.
Pharmaceuticals
NY
2020
Amended and Restated Sales Agreement between Acer Therapeutics Inc., Roth Capital Partners, LLC, and JonesTrading Institutional Services LLC
Equity Distribution Agreements
Acer Therapeutics Inc.
Pharmaceuticals
NY
2020
Acer Therapeutics Inc. Description of Registered Common Stock and Anti-Takeover Provisions
Stock Agreements
Acer Therapeutics Inc.
Pharmaceuticals
2020
Acer Therapeutics Inc. $50,000,000 Common Stock Sales Agreement with Roth Capital Partners, LLC (November 9, 2018)
Equity Distribution Agreements
Acer Therapeutics Inc.
Pharmaceuticals
NY
2018
Acer Therapeutics Inc. Underwriting Agreement with William Blair & Company, L.L.C. and Raymond James & Associates, Inc.
Underwriting Agreements
Acer Therapeutics Inc.
Pharmaceuticals
2018
Acer Therapeutics Inc. Common Stock Certificate Specimen
Stock Agreements
Acer Therapeutics Inc.
Pharmaceuticals
2018
Acer Therapeutics Inc. Underwriting Agreement with William Blair & Company, L.L.C. (December 12, 2017)
Underwriting Agreements
Acer Therapeutics Inc.
Pharmaceuticals
2017
Specimen common stock certificate
Stock Agreements
Acer Therapeutics Inc.
Pharmaceuticals
2017
Acer Therapeutics Inc. Subscription Agreement with Purchasers Dated June 30, 2017
Subscription Agreements
Acer Therapeutics Inc.
Pharmaceuticals
DE
2017
Assignment and Assumption of Lease Agreement between Opexa Therapeutics, Inc. and KBI Biopharma, Inc.
Assignment Agreements
Acer Therapeutics Inc.
Pharmaceuticals
TX
2017